United States · Platforms & data · TradingView

IDEXX Laboratories Q3 Revenue Rises 10%; Comparable EPS Reaches $3.96

Published by TradingView · United States 1 d ago

IDEXX Laboratories reported third-quarter 2026 revenue of $1.214 billion, up 10% year over year, and diluted EPS of $4.01. Comparable diluted EPS was $3.96, a 22% increase. The…

Read the full article on TradingView Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingview.com)

Also worth reading

CNBC

Earnings call transcript: Lattice Semiconductor tops Q3 2026 estimates, shares jump

MarketWatch

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

Benzinga

IDEXX Laboratories Q3 Revenue Rises 10%; Comparable EPS Reaches $3.96

Share

Also worth reading

Stock market after midterm elections: What S&P 500 history shows

Prediction: This Will Be SpaceX’s Stock Price by the End of 2027

Crescent Energy files for proposed IPO of royalty subsidiary

Earnings call transcript: Lattice Semiconductor tops Q3 2026 estimates, shares jump

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030